Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Which index type is best for passive investing? This guide compares index types, costs, and tracking performance to help you pick the most efficient option.
23,556 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Buffett’s moves often spark debates about dividend stocks. This article digs into the idea behind 'warren buffett own...
A top healthcare fund just lined up another $11 million in a biotech that’s surged 60%. We break down why the move ma...
A clash over 401(K) defaults intensifies as Suze Orman questions age-based glide paths and new needs-based approaches...
Sandisk stock sinking today grabbed headlines as intraday gains faded amid broader market jitters. This article break...
The AI IPO race is accelerating as OpenAI joins the fray after Anthropic. This article breaks down what the filing me...
As Buffett retires, Greg Abel takes the helm. Yet Berkshire’s quieter stock picker is delivering. This story breaks d...
As AI and cloud data reshape markets, two red-hot growth stocks 2026 could shine for bold investors. This guide break...
Two AI-driven stocks with durable moats and solid cash flow could deliver outperformance over the next five years. Ex...
Two top gene-editing names, two very different strategies. This guide breaks down CRISPR Therapeutics and Editas Medi...
As Brazil begins a measured rate-cut cycle, EWZ may emerge as a tactical edge in 2026. A slower Fed and a stronger BR...
GE Aerospace delivered strong results in 2026, but the broader XLI index outpaced the stock through July. Here's what...